{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:29:43Z","timestamp":1762025383046,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.humpath.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T02:54:33Z","timestamp":1600224873000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hepatocellular carcinomas can be Special AT-rich sequence-binding protein 2 positive: an important diagnostic pitfall"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-8796","authenticated-orcid":false,"given":"Whayoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2558-2583","authenticated-orcid":false,"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal S.","family":"Chandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.09.001_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1460-9568.2005.03897.x","article-title":"Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS","volume":"21","author":"Britanova","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.humpath.2020.09.001_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cell.2006.05.012","article-title":"SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation","volume":"125","author":"Dobreva","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2020.09.001_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/PAS.0b013e31821c3dae","article-title":"SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas","volume":"35","author":"Magnusson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.34","article-title":"A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer","volume":"106","author":"Eberhard","year":"2012","journal-title":"Br J Canc"},{"key":"10.1016\/j.humpath.2020.09.001_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.5858\/arpa.2016-0243-RS","article-title":"SATB2 as an immunohistochemical marker for colorectal adenocarcinoma a concise review of benefits and pitfalls","volume":"141","author":"Berg","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2020.09.001_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/his.14012","article-title":"SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours","volume":"76","author":"Hoskoppal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.09.001_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/his.13943","article-title":"SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas","volume":"76","author":"Bellizzi","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.09.001_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.semdp.2017.11.012","article-title":"Immunohistochemistry, carcinomas of unknown primary, and incidence rates","volume":"35","author":"Stelow","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/AJCPWW2URZ9JKQJU","article-title":"The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study","volume":"141","author":"Dragomir","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/PAS.0000000000000553","article-title":"SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type","volume":"40","author":"Moh","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ajcp\/aqx023","article-title":"Dual immunostain with SATB2 and CK20 differentiates appendiceal mucinous neoplasms from ovarian mucinous neoplasms","volume":"147","author":"Li","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/his.12899","article-title":"Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours","volume":"68","author":"Strickland","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.09.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151510","article-title":"SATB2 is frequently expressed in ossifying and non-ossifying peripheral oral fibroma of the gingival region but not in reactive fibromatous lesions from other intraoral sites","volume":"46","author":"Ban\u011b\u010dkov\u00e1","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00403-016-1655-6","article-title":"SATB2 is expressed in Merkel cell carcinoma","volume":"308","author":"Fukuhara","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.humpath.2020.09.001_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/his.12911","article-title":"Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas","volume":"69","author":"Davis","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.09.001_bib16","series-title":"WHO classification of tumors of the digestive system tumors","first-page":"229","article-title":"Hepatocellular carcinomas","author":"Torbenson","year":"2019"},{"key":"10.1016\/j.humpath.2020.09.001_bib17","doi-asserted-by":"crossref","first-page":"55368","DOI":"10.18632\/oncotarget.10552","article-title":"Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients","volume":"7","author":"de Ridder","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2020.09.001_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","article-title":"Metastatic patterns of cancers : results from a large autopsy study","volume":"132","author":"DiSibio","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2020.09.001_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","article-title":"Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases","volume":"32","author":"van der Geest","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.humpath.2020.09.001_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3350\/cmh.2018.0067","article-title":"Pathologic differential diagnosis of metastatic carcinoma in the liver","volume":"25","author":"Park","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.humpath.2020.09.001_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/apm.12854","article-title":"SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary","volume":"126","author":"Dabir","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2020.09.001_bib22","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.21873\/anticanres.12784","article-title":"Diagnostic utility of prostein, Uroplakin II and SATB2 for diagnosing carcinoma of unknown primary origin: a systematic immunohistochemical profiling","volume":"38","author":"Mochizuki","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2020.09.001_bib23","first-page":"1067","article-title":"A comparison of SATB2 expression results with CK20 and CDX2 in metastatic colorectal carcinoma cases","volume":"35","author":"Bozdag","year":"2019","journal-title":"Acta Med Mediterr"},{"key":"10.1016\/j.humpath.2020.09.001_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/aqx160","article-title":"Dual stain with SATB2 and CK20\/villin is useful to distinguish colorectal carcinomas from other tumors","volume":"149","author":"Li","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jclinpath-2015-203588","article-title":"Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas","volume":"69","author":"Kim","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib26","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/PAS.0000000000001116","article-title":"Loss of SATB2 expression in colorectal carcinoma is associated with DNA mismatch repair protein deficiency and BRAF mutation","volume":"42","author":"Ma","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41379-018-0198-0","article-title":"Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression","volume":"32","author":"Iwaya","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib28","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/PAS.0000000000001330","article-title":"Loss of SATB2 expression is a biomarker of inflammatory bowel disease-associated colorectal dysplasia and adenocarcinoma","volume":"43","author":"Ma","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ebiom.2018.01.001","article-title":"SATB2 is a promising biomarker for identifying a colorectal origin for liver metastatic adenocarcinomas","volume":"28","author":"Zhang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.humpath.2020.09.001_bib30","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.18632\/oncotarget.3265","article-title":"miR-211 suppresses hepatocellular carcinoma by downregulating SATB2","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2020.09.001_bib31","first-page":"11932","article-title":"SATB2 induces stem-like properties and promotes epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"10","author":"Gan","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib32","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1111\/jcmm.14652","article-title":"Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans","volume":"23","author":"Yu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humpath.2020.09.001_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.scr.2017.01.011","article-title":"Cellular transformation of human mammary epithelial cells by SATB2","volume":"19","author":"Yu","year":"2017","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.humpath.2020.09.001_bib34","doi-asserted-by":"crossref","first-page":"57783","DOI":"10.18632\/oncotarget.10860","article-title":"Role of SATB2 in human pancreatic cancer: implications in transformation and a promising biomarker","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2020.09.001_bib35","article-title":"SATB2\/\u03b2-catenin\/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer","volume":"7","author":"Yu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2020.09.001_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.2575","article-title":"Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer","volume":"219","author":"Wang","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2020.09.001_bib37","first-page":"3710","article-title":"Decreased SATB2 expression is associated with metastasis and poor prognosis in human clear cell renal cell carcinoma","volume":"8","author":"Guo","year":"2015","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:26Z","timestamp":1758645446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720301738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":37,"alternative-id":["S0046817720301738"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.09.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular carcinomas can be Special AT-rich sequence-binding protein 2 positive: an important diagnostic pitfall","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}